Say Hello!
Don’t be shy.

   

News

Leading early-stage drug discovery, purification specialist and contract research organisation (CRO) Reach Separations has expanded its Nottingham premises in the wake of increased demand for its chiral purification services. Reach Separations specialises in chromatography for the analysis and purification of small molecules, and has added 1580...

BioCity Nottingham based Selentus Science Ltd is pleased to announce that its patent for TenaTac®, an innovative, adhesive surgical haemostat, has been allowed for grant in the UK, following an earlier grant in the USA. TenaTac is a Class III CE marked medical device that...

BioCity investee company, Deep Branch, has secured further investment to scale up the sustainable generation of protein that could transform food production and supply chains. Complementing the REACT-FIRST project, the company is turning industrial emissions into novel protein sources for animal feed and now, with European Innovation Council...

SurePulse Medical Ltd, a neonatal medtech spinout from the University of Nottingham is set to explore foreign markets and grow its product portfolio thanks to £1m secured from existing and new private investors. SurePulse Medical Ltd, based at MediCity in Nottingham, was established in 2014 as...

Double Olympic champion, Commonwealth champion, and multiple world champion Alistair Brownlee (MBE) joins Incus Performance, as investor and strategic advisor. Alistair brings 15 years of experience at the highest level and will use this knowledge to help further develop the INCUS platform and product offering to...

OUTbio are delighted to announce the formation of the UK branch of OUTbio – an independent network run specifically for the LGBTQ community and its allies within the biotech community in the UK. We hosted our inaugural event on 30th September and virtually connected members...